arginyl-glycyl-aspartyl-serine and Skin Neoplasms

arginyl-glycyl-aspartyl-serine has been researched along with Skin Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Azuma, I; Fujii, H; Itoh, I; Kojima, M; Komazawa, H; Mori, H; Ono, M; Saiki, I	1

Other Studies

1 other study(ies) available for arginyl-glycyl-aspartyl-serine and Skin Neoplasms

Article	Year
Combination of anti-cell adhesive synthetic Arg-Gly-Asp-Ser analogue and anticancer drug doxorubicin heightens their original antimetastatic activities. Oncology research, 1995, Volume: 7, Issue:7-8 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Movement; Dose-Response Relationship, Drug; Doxorubicin; Female; Furans; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Invasiveness; Oligopeptides; Skin Neoplasms; Specific Pathogen-Free Organisms; Tumor Cells, Cultured	1995

Article

Year

Combination of anti-cell adhesive synthetic Arg-Gly-Asp-Ser analogue and anticancer drug doxorubicin heightens their original antimetastatic activities.

Oncology research, 1995, Volume: 7, Issue:7-8

Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Movement; Dose-Response Relationship, Drug; Doxorubicin; Female; Furans; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Invasiveness; Oligopeptides; Skin Neoplasms; Specific Pathogen-Free Organisms; Tumor Cells, Cultured

1995